Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone nanoparticles eye drops in diabetic macular edema
2017-001172-36Phase 2Completed
- Sponsor
- Oculis
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexamethasone in diabetic macular edema (DME), sponsored by Oculis. Primary endpoint: Change in ETDRS BCVA at 12 weeks. Started Apr 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2017-001172-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001172-36.